Article Text

Download PDFPDF

2018 ESMO Sarcoma and GIST Symposium: ‘take-home messages’ in soft tissue sarcoma
  1. Anna Maria Frezza1,
  2. Alex T J Lee2,
  3. Eran Nizri3,
  4. Marta Sbaraglia4,
  5. Robin L Jones2,
  6. Alessandro Gronchi5,
  7. Angelo Paolo Dei Tos4,
  8. Paolo G Casali1,6
  1. 1Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale Tumori, Milano, Italy
  2. 2Sarcoma Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK
  3. 3Department of Surgery A, Tel- Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel- Aviv University, Tel- Aviv, Israel
  4. 4Department of Pathology, Treviso Regional Hospital, Treviso, Italy
  5. 5Sarcoma Surgery, IRCCS Fondazione Istituto Nazionale Tumori, Milan, Italy
  6. 6Department of Medical Oncology and Haemato-Oncology, University of Milan, Milan, Italy
  1. Correspondence to Dr Anna Maria Frezza; annamaria.frezza{at}


The 7th edition of the ‘ESMO Sarcoma and GIST Symposium’ was held in Milan in February 2018. For the first time, the Symposium brought together representatives from the European Reference Network on rare adult solid cancer (EURACAN) joined by sarcoma experts from the USA, Japan and patient advocacy groups, to share insights and discuss future directions in this rare condition. This commentary will summarise the highlights in soft tissue sarcomas.

  • soft tissue sarcoma
  • euracan
  • epigenetics
  • immunotherapy
  • massive parallel sequencing

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:

View Full Text

Statistics from


  • Contributors AMF and PGC conceived the manuscript. All the authors contributed in drafting the paper, revising the contents critically and gave approval to the final version.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.